ePrints

Telomere Length in Peripheral Blood Mononuclear Cells of Patients on Chronic Hemodialysis Is Related With Telomerase Activity and Treatment Duration

Lookup NU author(s): Dr Axel Kowald

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Telomere shortening to a critical limit is associated with replicative senescence. This process is prevented by the enzyme telomerase. Oxidative stress and chronic inflammation are factors accelerating telomere loss. Chronic hemodialysis, typically accompanied by oxidative stress and inflammation, may be also associated with replicative senescence. To test this hypothesis, we determined telomere length and telomerase activity in peripheral blood mononuclear cells (PBMCs) in a cross-sectional study. Hemodialysis patients at the University Hospital Larissa and healthy controls were studied. Telomere length was determined by the TeloTAGGG Telomere Length Assay and telomerase activity by Telomerase PCR-ELISA (Roche Diagnostics GmbH, Mannheim, Germany). We enrolled 43 hemodialysis patients (17 females; age 65.0 +/- 12.7 years) and 23 controls (six females; age 62.1 +/- 15.7 years). Between the two groups, there was no difference in telomere length (6.95 +/- 3.25 vs. 7.31 +/- 1.96kb; P=0.244) or in telomerase activity (1.82 +/- 2.91 vs. 2.71 +/- 3.0; P=0.085). Telomere length correlated inversely with vintage of hemodialysis (r=-0.332, P=0.030). In hemodialysis patients, positive telomerase activity correlated with telomere length (r=0.443, P=0.030). Only age, and neither telomere length nor telomerase activity, was an independent survival predictor (hazard ratio 1.116, 95% confidence interval 1.009-1.234, P=0.033). In this study, telomere length and telomerase activity in PBMCs are not altered in hemodialysis patients compared with healthy controls. Long duration of hemodialysis treatment is associated with telomere shortening and positive telomerase activity with an increased telomere length in PBMCs of hemodialysis patients. The underlying mechanism and clinical implications of our findings require further investigation.

Publication metadata

Author(s): Stefanidis I, Voliotis G, Papanikolaou V, Chronopoulou I, Eleftheriadis T, Kowald A, Zintzaras E, Tsezou A

Publication type: Article

Publication status: Published

Journal: Artificial Organs

Year: 2015

Volume: 39

Issue: 9

Pages: 756-764

Print publication date: 01/09/2015

Online publication date: 20/04/2015

Acceptance date: 01/01/1900

ISSN (print): 0160-564X

ISSN (electronic): 1525-1594

Publisher: Wiley-Blackwell Publishing, Inc.

URL: http://dx.doi.org/10.1111/aor.12453

DOI: 10.1111/aor.12453

Altmetrics

Share